Barclays Maintains Overweight on Arcosa, Raises Price Target to $140

Arcosa, Inc.

Arcosa, Inc.

ACA

0.00

Barclays analyst Adam Seiden maintains Arcosa (NYSE: ACA) with a Overweight and raises the price target from $115 to $140.